Taking semaglutide alongside other medications: the practical picture

Does slowing digestion actually change how your other tablets work?

Semaglutide's mechanism (binding to GLP-1 receptors and slowing how fast food and liquids leave the stomach) is well understood. What that means for co-administered medicines is more nuanced. For most tablets and capsules, the slowdown in gastric emptying produces no meaningful clinical difference. Absorption does shift slightly in timing, but it generally doesn't change the total amount absorbed enough to matter.

The picture is different for medicines with a narrow therapeutic window, where even small absorption changes matter, or for medicines that need to peak quickly to work. Antibiotics taken for a short course are a common example: if a time-sensitive antibiotic needs rapid absorption, your prescriber may advise on timing relative to your weekly injection. Our dedicated page on whether Wegovy interacts with other medications goes into the pharmacology further if you want the deeper read.

The NHS patient-level guidance on semaglutide recommends telling every prescriber and pharmacist that you are on semaglutide before any new medicine is started, including over-the-counter purchases. That advice extends to supplements that affect blood glucose, since the impact of combining these with a GLP-1 medicine hasn't been formally studied in controlled trials. The NHS semaglutide medicines page lists the known interactions in plain language and is worth bookmarking.

Which drug classes get the most attention during semaglutide treatment?

Three categories of co-prescribed medicines come up in almost every clinical conversation about Wegovy and what it contains.

The first is insulin and other diabetes medicines, particularly sulphonylureas such as gliclazide or glibenclamide. Semaglutide itself lowers blood glucose, and combining it with medicines that also drive glucose down increases the chance of hypoglycaemia. Dose reductions of the diabetes medicine are often needed, and your prescriber will flag this at the outset. If you're monitoring your blood glucose at home, this is the period to keep a closer eye on readings.

The second is blood-pressure medication. Semaglutide doesn't directly affect antihypertensive drugs, but meaningful weight loss often lowers blood pressure on its own, which means a dose that was right before treatment may become too high as weight comes off. Medicines like ramipril are a frequent topic in this context; there's a specific page on Wegovy and ramipril if that's what you're taking.

Third are anticoagulants such as warfarin. Warfarin is notoriously sensitive to changes in absorption timing and diet. Patients on warfarin who start semaglutide should have their INR monitored more frequently in the first weeks of treatment. This isn't a reason to avoid semaglutide, but it is a reason to have an explicit plan with your anticoagulation team before the first pen arrives.

What about the oral contraceptive pill?

This is a question our prescribers hear regularly. The current NHS England position, based on available evidence, does not flag oral contraceptive absorption as a specific concern with semaglutide in the way it does with tirzepatide (Mounjaro). With tirzepatide, women are advised to add a non-oral contraceptive method for the first four weeks of treatment and after each dose increase. That same evidence base does not extend to semaglutide at present. NHS guidance on weight-management injections is clear on the distinction.

That said, individual clinical context matters. If you are on a very low-dose pill, or if there are other factors your prescriber considers relevant, additional contraceptive precautions may still be discussed. The broader point (that some medicines and semaglutide need careful co-management) holds even where the formal guidance is reassuring. Do not stop or change contraception without discussing it with a prescriber first. The MHRA advises using effective contraception while taking GLP-1 medicines and for a wash-out period before trying to conceive. Yellow Card is where you can report any unexpected effects once on treatment.

How does the consultation process handle your existing medication list?

At nume, the free consultation asks specifically about current and recent medications, prescription, over-the-counter and supplements. A real prescriber, not an automated system, reads those answers. If your list includes anything that warrants a closer look, they'll note it before anything is approved. That same clinical check happens at every repeat order, so if you start a new medicine three months into treatment, it's reviewed in context, because semaglutide can interact with a wider range of medicines than many people expect.

For the cost context (including what a privately supervised treatment plan actually runs to in the UK) the Wegovy price comparison guide lays out what different providers typically include (and what they sometimes don't). The consultation at nume is free, covers your full medication history, and there's no subscription pulling future orders through automatically. If you're ready to have your eligibility reviewed, check your eligibility with our prescribers and we'll take it from there.